- Abbott (NYSE:ABT -2.5%) Q1 results ($M): Total revenues: 7,390 (+16.7%).
- Medical Devices: 2,744 (+14.6%); Diagnostics: 1,837 (+58.7%); Nutrition: 1,756 (+7.0%); Pharmaceuticals: 1,044 (+9.9%).
- Net Income: 418 (-0.2%); non-GAAP net income (continuing ops): 1,050 (+24.6%); EPS: 0.23 (-4.2%); non-GAAP EPS: 0.59 (+22.9%).
- Shares are under modest pressure in apparent response to its slight miss of 7.0% organic sales growth consensus (6.9%). Non-GAAP earnings and total revenue beat consensus.
- Shares were up over 3% before reversing.